Key Takeaways
- Currently, no additional symptoms reported on the ship after an Andes virus case; precautions are advised.
- The Andes virus can be transmitted between individuals through prolonged contact; a similar outbreak occurred in Argentina in 2018-2019.
- No specific antiviral treatments exist for hantavirus; early intensive care is crucial for affected individuals.
Current Situation on the Ship
Maria Van Kerkhove, the WHO acting director for epidemic and pandemic management, announced that no other passengers on the ship have developed symptoms related to the Andes virus. This is considered a positive indicator; however, the virus has a lengthy incubation period of about six weeks. Passengers are being advised to wear medical masks when exiting their cabins to reduce the risk of transmission.
During the same press event, WHO Director-General Tedros Adhanom Ghebreyesus conveyed that morale among passengers has notably improved since the ship began its journey towards the Canary Islands, according to the ship’s captain.
Understanding the Andes Virus
The Andes virus is a unique hantavirus recognized for its potential person-to-person transmission, primarily occurring through prolonged, close contact. An outbreak of the Andes virus in Argentina from late 2018 to early 2019 resulted in 34 confirmed cases and 11 fatalities. This outbreak was notably traced back to an individual attending a social gathering while symptomatic. “We are in a similar situation right now,” Tedros remarked, highlighting the risk associated with clusters in confined spaces.
Despite the earlier outbreak’s limited scope, Tedros expressed cautious optimism. He indicated that if adequate public health measures are obeyed and countries demonstrate solidarity, the current outbreak might also stay limited.
Treatment and Recommendations for Hantavirus
Currently, there are no specific antiviral treatments or vaccines available for hantavirus infections. WHO experts recommend immediate intensive care for individuals who exhibit symptoms, a measure that can significantly improve survival rates. Anaïs Legand, WHO technical lead on viral hemorrhagic fevers, emphasized the importance of early intervention in managing such cases.
As the situation progresses, health authorities continue to monitor developments closely, ensuring that appropriate precautions are taken to safeguard public health.
The content above is a summary. For more details, see the source article.